JP2008509222A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509222A5
JP2008509222A5 JP2007525700A JP2007525700A JP2008509222A5 JP 2008509222 A5 JP2008509222 A5 JP 2008509222A5 JP 2007525700 A JP2007525700 A JP 2007525700A JP 2007525700 A JP2007525700 A JP 2007525700A JP 2008509222 A5 JP2008509222 A5 JP 2008509222A5
Authority
JP
Japan
Prior art keywords
methyloxy
naphthyridin
dihydro
oxo
pyrido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525700A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509222A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028107 external-priority patent/WO2006020561A2/en
Publication of JP2008509222A publication Critical patent/JP2008509222A/ja
Publication of JP2008509222A5 publication Critical patent/JP2008509222A5/ja
Pending legal-status Critical Current

Links

JP2007525700A 2004-08-09 2005-08-09 抗菌剤 Pending JP2008509222A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59993104P 2004-08-09 2004-08-09
PCT/US2005/028107 WO2006020561A2 (en) 2004-08-09 2005-08-09 Antibacterial agents

Publications (2)

Publication Number Publication Date
JP2008509222A JP2008509222A (ja) 2008-03-27
JP2008509222A5 true JP2008509222A5 (https=) 2008-09-25

Family

ID=35908073

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525700A Pending JP2008509222A (ja) 2004-08-09 2005-08-09 抗菌剤

Country Status (4)

Country Link
US (1) US20070161627A1 (https=)
EP (1) EP1784410A4 (https=)
JP (1) JP2008509222A (https=)
WO (1) WO2006020561A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655648B2 (en) * 2004-08-02 2010-02-02 Glaxo Group Limited Antibacterial agents
US7709472B2 (en) * 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
US7648980B2 (en) * 2005-01-25 2010-01-19 Glaxo Group Limited Antibacterial agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
EP2007377A4 (en) 2006-04-06 2011-08-17 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
WO2007115947A1 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
EA015821B1 (ru) * 2007-04-20 2011-12-30 Глэксо Груп Лимитед Трициклические азотсодержащие соединения в качестве антибактериальных агентов
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
ES2561631T3 (es) 2009-01-15 2016-02-29 Glaxo Group Limited Compuestos de naftiridin-2(1H)-ona útiles como agentes antibacterianos
AR090844A1 (es) * 2012-04-27 2014-12-10 Actelion Pharmaceuticals Ltd Proceso para elaborar derivados de naftiridina
JP6546654B2 (ja) 2014-08-22 2019-07-17 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ 淋菌感染を治療するための三環式含窒素化合物
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
US20220106308A1 (en) 2019-02-19 2022-04-07 Univerza V Ljubljani Antibacterials based on monocyclic fragments coupled to aminopiperidine naphthyridine scaffold

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
EA002817B1 (ru) * 1996-12-13 2002-10-31 Авентис Фармасьютикалз Продактс Инк. Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)азагетероциклиламида
US6602864B1 (en) * 1996-12-13 2003-08-05 Aventis Pharma Deutschland Gmbh Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
GB9824612D0 (en) * 1998-11-10 1999-01-06 Glynwed Metal Processing Limit A blind fastening device
CZ2003243A3 (cs) * 2000-07-26 2003-09-17 Smithkline Beecham P. L. C. Aminopiperidinové chinoliny a jejich azaisosterické analogy s antibakteriální aktivitou
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
WO2004035569A2 (de) * 2002-10-10 2004-04-29 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
TW200427688A (en) * 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
GB0412467D0 (en) * 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds

Similar Documents

Publication Publication Date Title
JP2008509222A5 (https=)
JP7297053B2 (ja) 神経変性疾患を治療するためのｅ３ユビキチンリガーゼ結合活性を有するキメラ（ｐｒｏｔａｃ）化合物を標的とし、アルファ－シヌクレインタンパク質を標的とするタンパク質分解
JP2008506695A5 (https=)
JP2008507543A5 (https=)
JP2009532504A5 (https=)
JP2008505920A5 (https=)
JP2005525324A5 (https=)
JP2008502689A5 (https=)
JP2013525438A5 (https=)
WO2016197114A1 (en) Tank-binding kinase-1 protacs and associated methods of use
JP2008505926A5 (https=)
JP4704755B2 (ja) 抗菌剤
JP2005504080A5 (https=)
ES2190570T3 (es) Compuestos heterociclicos de piperazinilo para el tratamiento de la demencia.
SE0402735D0 (sv) Novel compounds
TW200643015A (en) 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
CO5031253A1 (es) Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen
JP2007516194A5 (https=)
AR035235A1 (es) Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
AR031556A1 (es) Derivados de 3-(diarilmetilen)-8-azabiciclo[3.2.1] octano y composiciones farmaceuticas que los comprenden
JP2006505603A (ja) 抗菌剤
RU2000105266A (ru) Производные 1-(n-фениламиноалкил)-пиперазина, замещенные в положении 2 фенильного кольца
RU2014123109A (ru) Антибиотические производные 2-оксо-оксазолидин-3, 5-диила
AR060287A1 (es) Compuesto de 5,6 dihidro-3h-pirrolo[1,2,3-de]quinoxalini-3-ona, su uso para preparar un medicamento, composicion farmaceutica que lo comprende y compuesto intermediario util para su preparacion
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина